Descargar programa - MD Anderson Cancer Center Madrid

Transcripción

List of Faculty:
Dr. Luis M. Chiva
MD Anderson Cancer Center Madrid, Spain
Dr. Pedro T. Ramirez
The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Antonio González-Martín
DEALING WITH RARE OVARIAN TUMORS
Moderators:
Dr. Luis M. Chiva
12:15 - 12:35 Updates on novel therapies for rare tumors:
From chemotherapy to innovative therapies
Dr. David Gershenson
12:35 - 12:55 Overview of histopathologic classifications of rare tumors
Dr. Juan Fernando García
12:55 - 13:20 Discussion
13:20 - 15:00 Lunch
Moderator:
KEYNOTE LECTURE
15:00 - 15:20 Hereditary cancer genetics in the era of targeted therapies
Dr. Karen H. Lu
Professor and Chair H.E.B. Professorship in
Cancer Research Department Gynecologic Oncology & Reproductive Medicine
15:30 - 16:00 INAUGURATION BY AUTHORITIES
Wednesday, February 24th, 2016
Nadeem R. Abu-Rustum, Memorial Sloan Kettering Cancer Center. New York, USA
Giovanni Aletti, Istituto Europeo di Oncologia. Milan, Italy
Natalia Carballo, MD Anderson Cancer Center Madrid, Spain
Carlos Centeno, Clínica Universidad de Navarra. Pamplona, Spain
David Cibula, General University Hospital in Prague, Charles University. Prague, The Czech Republic
Robert L. Coleman, The University of Texas MD Anderson Cancer Center. Houston, USA
Nicoletta Colombo, Istituto Europeo di Oncologia. Milan, Italy
Luis M. Chiva, MD Anderson Cancer Center Madrid, Spain
Ben Davidson, The Norwegian Radium Hospital. Oslo, Norway
Andreas du Bois, Kliniken Essen Mitte. Essen, Germany
Pedro F. Escobar, Instituto Gyneco-Oncológico. San Juan, Puerto Rico
Anna Fagotti, Catholic University of the Sacred Heart. Rome, Italy
Michael M. Frumovitz, The University of Texas MD Anderson Cancer Center. Houston, USA
Juan Fernando García, MD Anderson Cancer Center Madrid, Spain
David M. Gershenson, The University of Texas MD Anderson Cancer Center. Houston, USA
Antonio González-Martín, MD Anderson Cancer Center Madrid, Spain
Anuja Jhingran, The University of Texas MD Anderson Cancer Center. Houston, USA
Matías Jurado, Clínica Universidad de Navarra. Pamplona, Spain
Fernando Lapuente, MD Anderson Cancer Center Madrid, Spain
Jonathan A. Ledermann, UCL Cancer Institute, University College. London, United Kingdom
Mario M. Leitao, Memorial Sloan Kettering Cancer Center. New York, USA
Karen H. Lu, The University of Texas MD Anderson Cancer Center. Houston, USA
Andrea Mariani, Mayo Clinic, Rochester. Minnesota, USA
Christian Marth, Medical University Innsbruck, Austria
Sergio Martínez, Hospital Clínic Universitari. Barcelona, Spain
Ignacio Melero, Clínica Universidad de Navarra. Pamplona, Spain
Mansoor R. Mirza, Rigshospitalet, Copenhagen University Hospital. Copenhagen, Denmark
Gema Moreno, MD Anderson Cancer Center Madrid, Spain
Ana Oaknin, Hospital General Vall d’Hebron. Barcelona, Spain
José Palacios, Hospital Universitario Ramón y Cajal. Madrid, Spain
Sandro Pignata, National Cancer Institute Fondazione Pascale. Naples, Italy
Jordi Ponce, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat. Barcelona, Spain
Andrés Poveda, Fundación Instituto Valenciano de Oncología. Valencia, Spain
Eric Pujade-Lauraine, Hôpital Hôtel-Dieu. Paris, France
Denis Querleu, Institut Bergonié. Bordeaux, France
Pedro T. Ramirez, The University of Texas MD Anderson Cancer Center. Houston, USA
Andrés Redondo, Hospital Universitario La Paz. Madrid, Spain
Ignacio Romero, Fundación Instituto Valenciano de Oncología. Valencia, Spain
Anil Sood, The University of Texas MD Anderson Cancer Center. Houston, USA
Ate Van der Zee, University Medical Center of Groningen, Netherlands
12:00 12:15 WELCOME REMARKS
Moderators:
Dr. Gema Moreno
Dr. José Palacios
Hospital Universitario Ramón y Cajal. Madrid, Spain
Dr. Ignacio Romero
Fundación Instituto Valenciano de Oncología. Valencia, Spain
16:00 - 16:20 Intra-tumor heterogeneity: Biological
and clinical implications
Dr. José Palacios
Hospital Universitario Ramón y Cajal. Madrid, Spain
16:20 - 16:40 Gene panel testing in gynecological cancer:
From the lab to the clinical practice
Dr. Gema Moreno
16:40 - 17:00 Clinical implications of molecular analysis
of serous effusions in ovarian cancer
Dr. Ben Davidson
The Norwegian Radium Hospital. Oslo, Norway
17:00 - 17:15
17:15 - 17:45
17:45 - 18:05
Discussion
Coffee break
Immunostimulatory monoclonal antibodies changing
the landscape of gyn-cancer treatment
Dr. Ignacio Melero
Clínica Universidad de Navarra. Pamplona, Spain
18:05 - 18:25 Targeting angiogenesis in ovarian cancer:
Overcoming adaptive responses
Dr. Anil Sood
18:25 - 18:45 Harnessing homologous recombination deficiency
for specialized treatment of ovarian cancer patients
Dr. Robert L. Coleman
18:45 - 19:00 Endpoints in ovarian cancer trials: Insights
from the 2015 SGO/ASCO/AACR FDA endpoints workshop
Dr. Robert L. Coleman
Moderators:
INDIVIDUALIZING THERAPY
IN ADVANCED OVARIAN CANCER
Dr. Andreas du Bois
Kliniken Essen Mitte. Essen, Germany
Dr. Sergio Martínez
Hospital Clínic Universitari. Barcelona, Spain
08:30 - 08:50 Assessment of quality in ovarian cancer surgery:
The ESGO perspective
Dr. Denis Querleu
Institut Bergonié. Bordeaux, France
Dr. Luis M. Chiva
08:50 - 09:10 Laparoscopic evaluation to assess cytoreduction
Dr. Anna Fagotti
Catholic University of the Sacred Heart. Rome, Italy
09:10 - 09:30 Clinical and radiologic assessment of feasibility
of cytoreduction
Dr. Giovanni Aletti
Istituto Europeo di Oncologia. Milan, Italy
09:30 - 09:50 Predictors of residual disease in patients
with ovarian cancer
Dr. Anil Sood
09:50 - 10:10 Adjuvant therapy in advanced ovarian cancer:
Moving beyond carboplatin and paclitaxel
Dr. Christian Marth
Medical University Innsbruck, Austria
10:40 - 11:10 Coffee break
Thursday, February 25th, 2016
Wednesday, February 24th, 2016
FROM LABORATORY MEDICINE
TO INNOVATIVE CLINICAL APPLICATIONS:
FOSTERING INNOVATION IN CONVERTING RESEARCH
DISCOVERIES TO CLINICAL IMPACT
INTEGRATING RECENT ADVANCES
INTO OPTIMIZING TREATMENT FOR WOMEN
WITH RECURRENT OVARIAN CANCER
Dr. Andrés Poveda
Fundación Instituto Valenciano de Oncología. Valencia, Spain
Dr. Sandro Pignata
National Cancer Institute Fondazione Pascale. Naples, Italy
Dr. Luis M. Chiva
Moderators: Dr. Jordi Ponce
Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat. Barcelona, Spain
Dr. Michael M. Frumovitz
Dr. Pedro F. Escobar
Instituto Gyneco-Oncológico. San Juan, Puerto Rico
11:10 - 11:30 Selecting the “really” ideal patient
for secondary cytoreduction
Dr. Andreas du Bois
14:40 - 15:00 Cervical cancer: Can we stop performing complete
lymphadenectomy?
11:30 - 11:50 Chemotherapy in the recurrent ovarian cancer setting: Relying on the “old standard” or is novel therapy
the new standard?
15:00 - 15:40 Endometrial cancer: Memorial Sloan-Kettering
vs. Mayo Clinic
Dr. Sandro Pignata
National Cancer Institute Fondazione Pascale. Naples, Italy
11:50 - 12:10 Critical review of PARPi’s in ovarian cancer therapy: How are we going to use them and when?
Dr. Jonathan A. Ledermann
UCL Cancer Institute, University College. London, United Kingdom
12:10 - 12:30 Integrating biological therapies in recurrent disease: Looking for the perfect algorithm
Dr. Eric Pujade-Lauraine
Hôpital Hôtel-Dieu. Paris, France
13:00 - 14:40 Lunch
Dr. David Cibula
General University Hospital in Prague, Charles University. Prague, The Czech Republic
Dr. Nadeem R. Abu-Rustum
Memorial Sloan Kettering Cancer Center. New York, USA
Dr. Andrea Mariani
Mayo Clinic, Rochester. Minnesota, USA
15:40 - 16:00 Vulvar cancer: Updates on current data and future trials
Dr. Ate Van der Zee
University Medical Center of Groningen, Netherlands
16:20 - 16:40 Personalizing targeted therapy in advanced/metastatic cervical cancer: The challenge of anti-angiogenesis therapy
Dr. Ana Oaknin
Hospital General Vall d’Hebron. Barcelona, Spain
Moderators:
SENTINEL LYMPH NODE IN GYNECOLOGIC ONCOLOGY:
A TIME TO SET NEW STANDARD OF CARE
Dr. Natalia Carballo
Dr. Andrés Redondo
Hospital Universitario La Paz. Madrid, Spain
Dr. Matías Jurado
17:10 - 17:30 Current and future clinical trials
in advanced/recurrent endometrial cancer
Dr. Mansoor R. Mirza
Rigshospitalet, Copenhagen University Hospital. Copenhagen, Denmark
17:30 - 17:50 Updates on standard care and novel approaches
for radiation oncology in uterine cancer
Dr. Anuja Jhingran
17:50 - 18:10 Reaching a consensus in endometrial cancer:
European guidelines (ESGO-ESTRO-ESMO)
Dr. Nicoletta Colombo
Istituto Europeo di Oncologia. Milan, Italy
PERSONALIZED MEDICINE IN GYNECOLOGIC
ONCOLOGY: LOOKING BEYOND STANDARDS
Moderators:
Dr. Luis M. Chiva
Dr. Karen H. Lu
08:30 - 08:45 Targeting stress neuroendocrine pathways in cancer
Dr. Anil Sood
08:45 - 09:00 Enhance recovery after surgery (ERAS)
09:00 - 09:20 Impact of early integration of palliative medicine
in the course of oncology treatment
Dr. Carlos Centeno
09:30 - 10:45 TUMOR BOARD
Moderator: Dr. Pedro T. Ramirez
Panel: Dr. David Gershenson
Dr. Karen H. Lu
Dr. Andreas du Bois
Dr. Nicoletta Colombo
Dr. Anuja Jhingran
Dr. José Palacios
Presenters:
1. Endometrial cancer with synchronous ovarian carcinoma?
2. A challenging locally advanced cervical cancer
Dr. Luis M. Chiva, Dr. Fernando Lapuente
3. Serous carcinoma of the ovary in two different clinical scenarios
Friday, February 26th, 2016
Moderators:
UPDATES ON THE MANAGEMENT
OF ENDOMETRIAL CANCER
10:45 - 11:15 MD ANDERSON SPAIN FOUNDATION AWARDS
A life devoted to a great endeavour: Gynecologic oncology
Dr. Andreas du Bois
Friday, February 26th, 2016
Moderators:
INNOVATIONS IN MINIMALLY
INVASIVE SURGERY
Dr. Michael M. Frumovitz
11:45 - 12:05 Update on robotic surgery in gynecologic oncology
Dr. Mario M. Leitao
12:05 - 12:25 Role of single-port surgery by laparoscopy or robotics: Surgical innovation or a procedure without a future?
Instituto Gyneco-Oncológico. San Juan, Puerto Rico
12:45 - 13:45 SURGICAL FILM FESTIVAL
Moderators:
Dr. Mario M. Leitao
Dr. David Cibula
• Ultra-radical laparoscopic abdominopelvic procedures
Dr. Nicanor Barrena
Pontificia Universidad Católica de Chile, Santiago de Chile
• Total pelvic exenteration plus IORT in recurrent cervical cancer
Dr. Teresa Castellanos, Dr. Sonsoles Alonso, Dr. Fernando Lapuente, Dr. Luis M. Chiva
• Vascular complication of left renal vein
Dr. Carlos Millán
Instituto Icera. Murcia, Spain
• Laparoscopic contained power morcellation:
techniques to avoid tumoral spread
Dr. Ignacio Zapardiel, Dr. Javier De Santiago
Hospital Universitario La Paz. Madrid, Spain
• Cytoreductive surgery of the upper abdomen
and the diaphragm, with a plasma device surgery system,
for advanced ovarian cancer
Dr. Gloria Cordeiro, Dr. Babin Guillaume, Dr. Denis Querleu, Dr. Guyon Frédéric
Institut Bergonié, Regional Comprehensive Cancer Center. Bordeaux-Aquitaine, France
• Cava vein injury during lymph node dissection
Dr. Julián Di Guilmi, Dr. C. Darin, Dr. AG. Maya
Hospital Británico de Buenos Aires, Argentina
• Sentinel node in vulvar cancer
Dr. Mario M. Leitao
• Modified rectus abdominis flap
for pelvic floor reconstruction after exenteration
Dr. David Cibula, Dr. M. Schneiderova, Dr. J. Slama, Dr. M. Zikan
13:45 - 13:55 CLOSING REMARKS
Dr. Luis M. Chiva
Local Committee:
Lucía Almeida
Sonsoles Alonso
Marisa Argente
Elsa Bernal
Raquel Bratos
Natalia Carballo
Teresa Castellanos
Luis M. Chiva
Virginia Corraliza
Marta de la Fuente
Irene Fernández
Juan Fernando García
Javier García Prado
Antonio González-Martín
Luis Granados
Fernando Lapuente
Pilar López Mendo
Raúl Márquez
Mar Mendivil
Manuel Morales
Gema Moreno
Mª Jesús Pablos
José Antonio Pérez Álvarez
Gemma Toledo
Covadonga Vidal

Descargar programa - MD Anderson Cancer Center Madrid

Transcripción

Documentos relacionados

Allemani 1050 def

Escuela de Matemáticas Lluís Santaló 2006: Mathematics and Biology